About
Sujin Kim is an Associate Research Scientist in the Department of Psychiatry at Yale University's School of Medicine. Her research focuses on molecular imaging, pharmacokinetics, and neuroscience, with particular expertise in PET radiotracer development and preclinical trials. She has contributed to studies on stem cell therapy for Parkinson's disease, neurobehavioral genetics, and imaging methodologies for drug response analysis. Her work integrates biomedical engineering and nanotechnology for dual-modal imaging applications. Key areas include optimizing radioligand binding quantification and developing novel imaging techniques for clinical and preclinical settings.
- Expertise: Molecular Imaging, Neuroscience, Pharmacokinetics
- Notable Projects: Clinical trial assessment of hESC-derived dopaminergic progenitors
- Techniques: Particle swarm optimization for parameter estimation, bioorthogonal nanoparticle conjugation
Her research bridges clinical practice and advanced imaging technologies, with applications in neurodegenerative disorders and drug development.
